Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs IPCA LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA IPCA LABS TORRENT PHARMA/
IPCA LABS
 
P/E (TTM) x 56.9 47.6 119.6% View Chart
P/BV x 13.7 5.0 277.2% View Chart
Dividend Yield % 0.9 0.4 249.5%  

Financials

 TORRENT PHARMA   IPCA LABS
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
IPCA LABS
Mar-23
TORRENT PHARMA/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs1,7231,062 162.2%   
Low Rs1,243768 161.8%   
Sales per share (Unadj.) Rs284.2243.0 117.0%  
Earnings per share (Unadj.) Rs36.819.4 189.7%  
Cash flow per share (Unadj.) Rs57.729.7 194.2%  
Dividends per share (Unadj.) Rs22.004.00 550.0%  
Avg Dividend yield %1.50.4 339.4%  
Book value per share (Unadj.) Rs183.1230.3 79.5%  
Shares outstanding (eoy) m338.45253.70 133.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.23.8 138.5%   
Avg P/E ratio x40.347.2 85.4%  
P/CF ratio (eoy) x25.730.8 83.5%  
Price / Book Value ratio x8.14.0 203.8%  
Dividend payout %59.820.6 289.9%   
Avg Mkt Cap Rs m501,779232,120 216.2%   
No. of employees `000NANA-   
Total wages/salary Rs m16,77712,876 130.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m96,20261,642 156.1%  
Other income Rs m6321,518 41.7%   
Total revenues Rs m96,83463,160 153.3%   
Gross profit Rs m28,2409,033 312.6%  
Depreciation Rs m7,0662,616 270.1%   
Interest Rs m3,334482 691.9%   
Profit before tax Rs m18,4727,453 247.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,0192,534 237.6%   
Profit after tax Rs m12,4524,919 253.1%  
Gross profit margin %29.414.7 200.3%  
Effective tax rate %32.634.0 95.9%   
Net profit margin %12.98.0 162.2%  
BALANCE SHEET DATA
Current assets Rs m53,13751,893 102.4%   
Current liabilities Rs m54,47318,058 301.7%   
Net working cap to sales %-1.454.9 -2.5%  
Current ratio x1.02.9 33.9%  
Inventory Days Days1551 30.2%  
Debtors Days Days76 125.9%  
Net fixed assets Rs m91,39034,336 266.2%   
Share capital Rs m1,692254 667.0%   
"Free" reserves Rs m60,28858,167 103.6%   
Net worth Rs m61,98158,420 106.1%   
Long term debt Rs m24,9626,518 383.0%   
Total assets Rs m144,68286,229 167.8%  
Interest coverage x6.516.5 39.7%   
Debt to equity ratio x0.40.1 361.0%  
Sales to assets ratio x0.70.7 93.0%   
Return on assets %10.96.3 174.2%  
Return on equity %20.18.4 238.6%  
Return on capital %25.112.2 205.3%  
Exports to sales %21.842.9 50.9%   
Imports to sales %013.3 0.0%   
Exports (fob) Rs m20,99426,434 79.4%   
Imports (cif) Rs mNA8,178 0.0%   
Fx inflow Rs m20,99426,434 79.4%   
Fx outflow Rs m3,7358,178 45.7%   
Net fx Rs m17,25918,257 94.5%   
CASH FLOW
From Operations Rs m23,6818,058 293.9%  
From Investments Rs m-24,153-7,250 333.1%  
From Financial Activity Rs m7745,072 15.3%  
Net Cashflow Rs m1,1015,881 18.7%  

Share Holding

Indian Promoters % 71.3 46.3 153.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.3 44.8 47.6%  
FIIs % 14.1 10.3 137.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.8 53.7 53.5%  
Shareholders   69,117 82,809 83.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Torrent Pharma vs IPCA Labs

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Torrent Pharma vs IPCA Labs Share Price Performance

Period Torrent Pharma IPCA Labs S&P BSE HEALTHCARE
1-Day -2.10% -2.20% -1.50%
1-Month -3.88% -7.07% -5.53%
1-Year 65.12% 45.99% 56.62%
3-Year CAGR 27.77% 7.41% 17.93%
5-Year CAGR 21.85% 19.90% 18.75%

* Compound Annual Growth Rate

Here are more details on the Torrent Pharma share price and the IPCA Labs share price.

Moving on to shareholding structures...

The promoters of Torrent Pharma hold a 71.3% stake in the company. In case of IPCA Labs the stake stands at 46.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Torrent Pharma and the shareholding pattern of IPCA Labs.

Finally, a word on dividends...

In the most recent financial year, Torrent Pharma paid a dividend of Rs 22.0 per share. This amounted to a Dividend Payout ratio of 59.8%.

IPCA Labs paid Rs 4.0, and its dividend payout ratio stood at 20.6%.

You may visit here to review the dividend history of Torrent Pharma, and the dividend history of IPCA Labs.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.